(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.62% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Qiagen Nv's revenue in 2025 is $2,040,067,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $452,403,851,250, with the lowest QGEN revenue forecast at $447,303,491,700, and the highest QGEN revenue forecast at $456,043,544,450. On average, 7 Wall Street analysts forecast QGEN's revenue for 2026 to be $477,220,594,305, with the lowest QGEN revenue forecast at $472,052,099,350, and the highest QGEN revenue forecast at $480,376,373,750.
In 2027, QGEN is forecast to generate $510,875,783,730 in revenue, with the lowest revenue forecast at $506,931,766,900 and the highest revenue forecast at $516,030,999,900.